Literature DB >> 2429930

Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli.

B E Guth, E M Twiddy, L R Trabulsi, R K Holmes.   

Abstract

Type II heat-labile enterotoxin (LT-II) from Escherichia coli 41 was purified and compared with prototype LT-II encoded by genes from E. coli SA53. Both toxins were oligomeric proteins consisting of polypeptides A (Mr, 28,000) and B (Mr, 11,800). The A polypeptides were cleaved by trypsin into fragments A1 (Mr, 21,000) and A2 (Mr, about 7,000). These two toxins were shown to belong to two different subclasses of LT-II. We propose to designate the prototype toxin LT-IIa and the new variant LT-IIb. The pI of LT-IIb was between 5.2 and 5.6, significantly lower than the pI of 6.8 for LT-IIa, and the behavior of LT-IIb during purification differed significantly from that of LT-IIa. The toxic dose of unnicked LT-IIb in the Y1 adrenal-cell assay was 94 pg, but trypsin-treated, nicked LT-IIb was toxic at about 3 pg. In contrast, the toxic dose of LT-IIa was previously shown to be 0.5 to 1 pg for several preparations that varied from unnicked to partially nicked, and treatment with trypsin was not required for full toxicity. The titer of LT-II antiserum in neutralization tests was 100-fold greater against LT-IIa than against LT-IIb. In immunodiffusion tests, LT-IIa and LT-IIb gave a reaction of partial identity. In a radioimmunobinding assay, the titer of LT-IIa antiserum against homologous LT-IIa was approximately 10-fold greater than against LT-IIb. The cholera-E. coli family of heat-labile enterotoxins has been divided into serogroup I, which includes cholera toxin and the antigenic variants of E. coli heat-labile toxin designated LTh-I and LTp-I, and serogroup II, which includes LT-IIa and LT-IIb. The type I and type II toxins do not cross-react in neutralization or immunodiffusion tests. By using very sensitive radioimmunobinding assays, it was possible to demonstrate common antigenic determinants between the type I and type II toxins. However, the titers of antibodies in hyperimmune sera that recognized these common determinants were very low.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429930      PMCID: PMC260193          DOI: 10.1128/iai.54.2.529-536.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Escherichia coli heat-labile enterotoxin. Nucleotide sequence of the A subunit gene.

Authors:  E K Spicer; J A Noble
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

2.  Synthesis of plasmid-coded heat-labile enterotoxin in wild-type and hypertoxinogenic strains of Escherichia coli and in other genera of Enterobacteriaceae.

Authors:  R J Neill; E M Twiddy; R K Holmes
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

3.  Molecular organization of heat-labile enterotoxin genes originating in Escherichia coli of human origin and construction of heat-labile toxoid-producing strains.

Authors:  T Yamamoto; T Yokota; A Kaji
Journal:  J Bacteriol       Date:  1981-12       Impact factor: 3.490

4.  Analysis of antigenic determinants in cholera enterotoxin and heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli.

Authors:  Y Takeda; T Honda; H Sima; T Tsuji; T Miwatani
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

5.  Immunological and physicochemical characterization of heat-labile enterotoxins isolated from two strains of Escherichia coli.

Authors:  J D Clements; D C Flint; F A Klipstein
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits.

Authors:  M Robb; J C Nichols; S K Whoriskey; J R Murphy
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin.

Authors:  L Lindholm; J Holmgren; M Wikström; U Karlsson; K Andersson; N Lycke
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  Evidence that a new enterotoxin of Escherichia coli which activates adenylate cyclase in eucaryotic target cells is not plasmid mediated.

Authors:  B A Green; R J Neill; W T Ruyechan; R K Holmes
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

9.  Production and characterization of monoclonal antibodies to cholera toxin.

Authors:  E F Remmers; R R Colwell; R A Goldsby
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Conformity between heat-labile toxin genes from human and porcine enterotoxigenic Escherichia coli.

Authors:  W S Dallas
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more
  31 in total

1.  Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways.

Authors:  Ramiro H Massol; Jakob E Larsen; Yukako Fujinaga; Wayne I Lencer; Tomas Kirchhausen
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

2.  In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis.

Authors:  Sergio Arce; Hesham F Nawar; Gwendolin Muehlinghaus; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 3.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

Review 4.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

5.  Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles; A Valdivieso-Garcia; R C Clarke
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Purification and characterization of a Chinese hamster ovary cell elongation factor of Vibrio hollisae.

Authors:  M H Kothary; E F Claverie; M D Miliotis; J M Madden; S H Richardson
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation.

Authors:  P P Chang; J Moss; E M Twiddy; R K Holmes
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

9.  LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.

Authors:  Hesham F Nawar; Christopher J Greene; Chang Hoon Lee; Lorrie M Mandell; George Hajishengallis; Terry D Connell
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

10.  Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.

Authors:  Hesham F Nawar; Sergio Arce; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.